Winners And Losers Under Bold Trump Plan To Slash Drug Rebate Deals
(By Jay Hancock for Kaiser Health News) Few consumers have heard of the secret, business-to-business payments that the Trump administration
Read More
Legislative Update
Congress Wades Into Emotional Debate Over High-Cost Prescription Drugs
(By Emmarie Huetteman and Rachel Bluth for Kaiser Health News) Senators railed against pharmaceutical executives Tuesday for declining to testify
Read MoreAs Congress returns, lawmakers rush to detail drug-pricing agendas
(By Lev Facher for ST A T) W ASHINGTON — Chuck Grassley wasted little time this week in unveiling his
Read MoreMedicaid ‘Buy-In’ Could Be a New Health Care Option for the Uninsured
(By Michael Ollove for Stateline , an initiative of The Pew Charitable Trusts) Even as calls for “Medicare for All”
Read MoreHow PhRMA finally lost: the inside story of the group’s biggest lobbying failure in years
(By Nicholas Florko for ST A T) W ASHINGTON —The drug industry’s storied lobbying group isn’t accustomed to bad news
Read MoreJudge blocks Trump administration cuts to 340B hospital drug-discount program
(By Ike Swetlitz for ST A T) A federal judge has blocked a Trump administration policy that reduces payments to
Read More3 state legislative battles to watch in 2019
(By Lev Facher for ST A T) W ASHINGTON — Drug pricing is on the agenda here in 2019. But
Read MorePowerful Democrat wants Pfizer to explain price hikes for Lyrica, its nerve pain drug
(By Nicholas Florko for ST A T) W ASHINGTON — A powerful Senate Democrat is asking Pfizer to explain why
Read MoreBipartisan action on surprise medical bills expected next year, senator says
(By Kelly Gooch for Becker’s Hospital Review ) U.S. Sen. Bill Cassidy, R-La., said federal lawmakers on both sides of
Read MoreSen. Cory Booker Calls For More Transparency In Medicaid Drug Decisions
(By Liz Whyte for NPR and The Center for Public Integrity) Sen. Cory Booker, D-N.J., says he will introduce federal
Read More